Roche Translational Cancer Research Fellowship
Since 2016, Roche has been partnering with the New Zealand Society for Oncology (NZSO) to award the Roche Translational Cancer Research Fellowship. Their generous contribution to this award is $40,000 in order to support translational cancer research to a fellowship winner.
Both Roche and NZSO recognise the importance of keeping up-to-date with international developments in cancer research and oncology clinical practice.
Translational research bridges the gap from basic science in the lab to clinical practice, in order to enhance human health and well-being. It’s sometimes referred to as bench to bedside to community. Research is most effective when clinicians and scientists work together and a key role of NZSO is to encourage collaboration between clinicians and scientists.
This award provides a unique opportunity for NZ cancer research teams to enable an integral team member (the Roche Fellow) and carry out novel, cutting-edge translational research, or access platforms and technology not available in NZ.
Applications close Friday 15th August 2025.
Click the below boxes for more information.